- Report
- January 2026
- 185 Pages
Global
From €4056EUR$4,500USD£3,485GBP
- Report
- September 2026
- 198 Pages
Global
From €3196EUR$3,545USD£2,746GBP
€3551EUR$3,939USD£3,051GBP
- Report
- February 2026
- 250 Pages
Global
From €4047EUR$4,490USD£3,477GBP
- Report
- September 2026
- 220 Pages
Global
From €5273EUR$5,850USD£4,531GBP
- Report
- August 2026
- 160 Pages
Global
From €2993EUR$3,320USD£2,571GBP
€3741EUR$4,150USD£3,214GBP
- Report
- January 2026
- 160 Pages
Global
From €2849EUR$3,160USD£2,447GBP
€3561EUR$3,950USD£3,059GBP
- Report
- September 2026
- 421 Pages
Global
From €6306EUR$6,995USD£5,418GBP
- Report
- November 2025
- 150 Pages
Global
From €5364EUR$5,950USD£4,608GBP
- Report
- January 2026
- 180 Pages
Global
From €4056EUR$4,500USD£3,485GBP
- Report
- September 2026
- 180 Pages
Global
From €3196EUR$3,545USD£2,746GBP
€3551EUR$3,939USD£3,051GBP
- Report
- May 2026
- 250 Pages
Global
From €4047EUR$4,490USD£3,477GBP
- Report
- May 2026
- 250 Pages
Global
From €4047EUR$4,490USD£3,477GBP
- Report
- March 2026
- 250 Pages
Global
From €4047EUR$4,490USD£3,477GBP
- Report
- February 2026
- 250 Pages
Global
From €4047EUR$4,490USD£3,477GBP
- Report
- February 2026
- 250 Pages
Global
From €4047EUR$4,490USD£3,477GBP
- Report
- September 2026
- 282 Pages
Global
From €5273EUR$5,850USD£4,531GBP
- Report
- September 2026
- 174 Pages
Global
From €5273EUR$5,850USD£4,531GBP
- Report
- August 2026
- 145 Pages
Global
From €4282EUR$4,750USD£3,679GBP
- Report
- May 2026
- 140 Pages
Global
From €4282EUR$4,750USD£3,679GBP
- Report
- August 2026
- 160 Pages
Global
From €2993EUR$3,320USD£2,571GBP
€3741EUR$4,150USD£3,214GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more